News
US Med-Equip Opens Tucson Branch to Help Regional Hospitals Access Critical Medical Equipment Faster
Rising Demand Spurs US Med-Equip Expansion Across Arizona and the Southwest TUCSON, ARIZONA / ACCESS Newswire / May 1, 2025 / ...
Marks second acquisition in Northeast Ohio; name will change to Saint Therese of Westlake ST. LOUIS PARK, MN / ACCESS ...
Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...
Robust project management is essential in any manufacturing business, particularly where strict regulations and complex ...
PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global ...
LAS VEGAS, NV / ACCESS Newswire / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce ...
Aviva’s in-house capital unit that invests in a range of infrastructure and real estate projects, and mixed-use developer ...
SPOKANE, WA / ACCESS Newswire / May 1, 2025 / Singleton Schreiber is proud to welcome former U.S. Attorney Vanessa Waldref and former Assistant U.S. Attorney Dan Fruchter as partners in the firm's ...
Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again ...
Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...
Third-party benefit administrators to gather for discussions on regulatory changes, cost containment strategies, and emerging innovations shaping the future of self-funded healthcare ST. LOUIS, MO / ...
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces that the first patient has been enrolled in the Phase 1 clinical trial of its drug candidate 177Lu ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results